BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Godlewski G, Offertáler L, Wagner JA, Kunos G. Receptors for acylethanolamides-GPR55 and GPR119. Prostaglandins Other Lipid Mediat 2009;89:105-11. [PMID: 19615459 DOI: 10.1016/j.prostaglandins.2009.07.001] [Cited by in Crossref: 137] [Cited by in F6Publishing: 136] [Article Influence: 11.4] [Reference Citation Analysis]
Number Citing Articles
1 Avraham Y, Katzhendler J, Vorobeiv L, Merchavia S, Listman C, Kunkes E, Harfoush F, Salameh S, Ezra AF, Grigoriadis NC, Berry EM, Najajreh Y. Novel Acylethanolamide Derivatives That Modulate Body Weight through Enhancement of Hypothalamic Pro-Opiomelanocortin (POMC) and/or Decreased Neuropeptide Y (NPY). J Med Chem 2013;56:1811-29. [DOI: 10.1021/jm300484d] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
2 Liu J, Parsons L, Pope C. Comparative effects of parathion and chlorpyrifos on endocannabinoid and endocannabinoid-like lipid metabolites in rat striatum. Neurotoxicology 2015;50:20-7. [PMID: 26215119 DOI: 10.1016/j.neuro.2015.07.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
3 Henstridge CM, Balenga NA, Kargl J, Andradas C, Brown AJ, Irving A, Sanchez C, Waldhoer M. Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55. Mol Endocrinol 2011;25:1835-48. [PMID: 21964594 DOI: 10.1210/me.2011-1197] [Cited by in Crossref: 103] [Cited by in F6Publishing: 98] [Article Influence: 10.3] [Reference Citation Analysis]
4 Ramírez-Orozco RE, García-Ruiz R, Morales P, Villalón CM, Villafán-Bernal JR, Marichal-Cancino BA. Potential metabolic and behavioural roles of the putative endocannabinoid receptors GPR18, GPR55 and GPR119 in feeding. Curr Neuropharmacol 2019;17:947-60. [PMID: 31146657 DOI: 10.2174/1570159X17666190118143014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
5 Zhao J, Zhao Y, Hu Y, Peng J. Targeting the GPR119/incretin axis: a promising new therapy for metabolic-associated fatty liver disease. Cell Mol Biol Lett 2021;26:32. [PMID: 34233623 DOI: 10.1186/s11658-021-00276-7] [Reference Citation Analysis]
6 Ambrosini A, Fiorini R, Zolese G. Endocannabinoids and Human Sperm Cells. Pharmaceuticals 2010;3:3200-11. [DOI: 10.3390/ph3103200] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
7 Kalliomäki J, Annas P, Huizar K, Clarke C, Zettergren A, Karlsten R, Segerdahl M. Evaluation of the analgesic efficacy and psychoactive effects of AZD1940, a novel peripherally acting cannabinoid agonist, in human capsaicin-induced pain and hyperalgesia. Clin Exp Pharmacol Physiol 2013;40:212-8. [PMID: 23324098 DOI: 10.1111/1440-1681.12051] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
8 Hoyle CH. Evolution of neuronal signalling: Transmitters and receptors. Autonomic Neuroscience 2011;165:28-53. [DOI: 10.1016/j.autneu.2010.05.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
9 Cravens EM, Kirkwood JS, Wolfe LM, Packer RA, Whalen LR, Wojda SJ, Prenni JE, Florant GL, Donahue SW. The effects of neurectomy and hibernation on bone properties and the endocannabinoid system in marmots (Marmota flaviventris). Comp Biochem Physiol A Mol Integr Physiol 2020;241:110621. [PMID: 31783174 DOI: 10.1016/j.cbpa.2019.110621] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Karl T, Garner B, Cheng D. The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease. Behav Pharmacol 2017;28:142-60. [PMID: 27471947 DOI: 10.1097/FBP.0000000000000247] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 6.3] [Reference Citation Analysis]
11 Orio L, Alen F, Pavón FJ, Serrano A, García-Bueno B. Oleoylethanolamide, Neuroinflammation, and Alcohol Abuse. Front Mol Neurosci 2018;11:490. [PMID: 30687006 DOI: 10.3389/fnmol.2018.00490] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 14.5] [Reference Citation Analysis]
12 Davis MP, Behm B, Mehta Z, Fernandez C. The Potential Benefits of Palmitoylethanolamide in Palliation: A Qualitative Systematic Review. Am J Hosp Palliat Care 2019;36:1134-54. [PMID: 31113223 DOI: 10.1177/1049909119850807] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
13 Liu C, Qi X, Yang D, Neely A, Zhou Z. The effects of cannabis use on oral health. Oral Dis 2020;26:1366-74. [DOI: 10.1111/odi.13246] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Filipeanu CM, Guidry JJ, Leonard ST, Winsauer PJ. Δ9-THC increases endogenous AHA1 expression in rat cerebellum and may modulate CB1 receptor function during chronic use. J Neurochem 2011;118:1101-12. [PMID: 21781118 DOI: 10.1111/j.1471-4159.2011.07391.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
15 Pesce M, Seguella L, Cassarano S, Aurino L, Sanseverino W, Lu J, Corpetti C, Del Re A, Vincenzi M, Sarnelli G, Esposito G. Phytotherapics in COVID19: Why palmitoylethanolamide? Phytother Res 2020. [PMID: 33296131 DOI: 10.1002/ptr.6978] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
16 Kruk-Slomka M, Dzik A, Budzynska B, Biala G. Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes-a Short Review. Mol Neurobiol 2017;54:8332-47. [PMID: 27924524 DOI: 10.1007/s12035-016-0313-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
17 Serrano A, Rivera P, Pavon FJ, Decara J, Suárez J, Rodriguez de Fonseca F, Parsons LH. Differential effects of single versus repeated alcohol withdrawal on the expression of endocannabinoid system-related genes in the rat amygdala. Alcohol Clin Exp Res 2012;36:984-94. [PMID: 22141465 DOI: 10.1111/j.1530-0277.2011.01686.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 4.8] [Reference Citation Analysis]
18 Puhl SL. Cannabinoid-sensitive receptors in cardiac physiology and ischaemia. Biochim Biophys Acta Mol Cell Res 2020;1867:118462. [PMID: 30890410 DOI: 10.1016/j.bbamcr.2019.03.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
19 Boccella S, Cristiano C, Romano R, Iannotta M, Belardo C, Farina A, Guida F, Piscitelli F, Palazzo E, Mazzitelli M, Imperatore R, Tunisi L, de Novellis V, Cristino L, Di Marzo V, Calignano A, Maione S, Luongo L. Ultra-micronized palmitoylethanolamide rescues the cognitive decline-associated loss of neural plasticity in the neuropathic mouse entorhinal cortex-dentate gyrus pathway. Neurobiol Dis 2019;121:106-19. [PMID: 30266286 DOI: 10.1016/j.nbd.2018.09.023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
20 Roncati L, Lusenti B, Pellati F, Corsi L. Micronized / ultramicronized palmitoylethanolamide (PEA) as natural neuroprotector against COVID-19 inflammation. Prostaglandins Other Lipid Mediat 2021;154:106540. [PMID: 33636368 DOI: 10.1016/j.prostaglandins.2021.106540] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Haskó J, Fazakas C, Molnár J, Nyúl-Tóth Á, Herman H, Hermenean A, Wilhelm I, Persidsky Y, Krizbai IA. CB2 receptor activation inhibits melanoma cell transmigration through the blood-brain barrier. Int J Mol Sci 2014;15:8063-74. [PMID: 24815068 DOI: 10.3390/ijms15058063] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
22 Katz LB, Gambale JJ, Rothenberg PL, Vanapalli SR, Vaccaro N, Xi L, Sarich TC, Stein PP. Effects of JNJ-38431055, a novel GPR119 receptor agonist, in randomized, double-blind, placebo-controlled studies in subjects with type 2 diabetes. Diabetes Obes Metab. 2012;14:709-716. [PMID: 22340428 DOI: 10.1111/j.1463-1326.2012.01587.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 8.4] [Reference Citation Analysis]
23 West JM, Zvonok N, Whitten KM, Vadivel SK, Bowman AL, Makriyannis A. Biochemical and mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase inhibition. PLoS One 2012;7:e43877. [PMID: 22952796 DOI: 10.1371/journal.pone.0043877] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
24 Tegeder I. Endocannabinoids as Guardians of Metastasis. Int J Mol Sci 2016;17:230. [PMID: 26875980 DOI: 10.3390/ijms17020230] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
25 De Luca R, Mazur K, Kernder A, Suvorava T, Kojda G, Haas HL, Sergeeva OA. Mechanisms of N-oleoyldopamine activation of central histaminergic neurons. Neuropharmacology 2018;143:327-38. [DOI: 10.1016/j.neuropharm.2018.09.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
26 Leishman E, Cornett B, Spork K, Straiker A, Mackie K, Bradshaw HB. Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain. Pharmacol Res 2016;110:159-72. [PMID: 27109320 DOI: 10.1016/j.phrs.2016.04.020] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
27 Karasu T, Marczylo TH, Maccarrone M, Konje JC. The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility. Hum Reprod Update 2011;17:347-61. [PMID: 21227997 DOI: 10.1093/humupd/dmq058] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 6.5] [Reference Citation Analysis]
28 Benyó Z, Ruisanchez É, Leszl-Ishiguro M, Sándor P, Pacher P. Endocannabinoids in cerebrovascular regulation. Am J Physiol Heart Circ Physiol 2016;310:H785-801. [PMID: 26825517 DOI: 10.1152/ajpheart.00571.2015] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
29 Krott LM, Piscitelli F, Heine M, Borrino S, Scheja L, Silvestri C, Heeren J, Di Marzo V. Endocannabinoid regulation in white and brown adipose tissue following thermogenic activation. J Lipid Res 2016;57:464-73. [PMID: 26768656 DOI: 10.1194/jlr.M065227] [Cited by in Crossref: 36] [Cited by in F6Publishing: 15] [Article Influence: 7.2] [Reference Citation Analysis]
30 Bishay P, Häussler A, Lim HY, Oertel B, Galve-Roperh I, Ferreirós N, Tegeder I. Anandamide deficiency and heightened neuropathic pain in aged mice. Neuropharmacology 2013;71:204-15. [PMID: 23597506 DOI: 10.1016/j.neuropharm.2013.03.021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
31 Félétou M. The Endothelium, Part I: Multiple Functions of the Endothelial Cells -- Focus on Endothelium-Derived Vasoactive Mediators. Colloquium Series on Integrated Systems Physiology: From Molecule to Function 2011;3:1-306. [DOI: 10.4199/c00031ed1v01y201105isp019] [Cited by in Crossref: 36] [Cited by in F6Publishing: 1] [Article Influence: 3.6] [Reference Citation Analysis]
32 Wasilewski A, Storr M, Zielińska M, Fichna J. Role of G protein-coupled orphan receptors in intestinal inflammation: novel targets in inflammatory bowel diseases. Inflamm Bowel Dis 2015;21:666-73. [PMID: 25461621 DOI: 10.1097/MIB.0000000000000258] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Maccarrone M, Rapino C, Francavilla F, Barbonetti A. Cannabinoid signalling and effects of cannabis on the male reproductive system. Nat Rev Urol 2021;18:19-32. [PMID: 33214706 DOI: 10.1038/s41585-020-00391-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
34 Davenport AP, Alexander SP, Sharman JL, Pawson AJ, Benson HE, Monaghan AE, Liew WC, Mpamhanga CP, Bonner TI, Neubig RR. International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands. Pharmacol Rev. 2013;65:967-986. [PMID: 23686350 DOI: 10.1124/pr.112.007179] [Cited by in Crossref: 178] [Cited by in F6Publishing: 169] [Article Influence: 22.3] [Reference Citation Analysis]
35 Chang YD, Jung JW, Oberoi-Jassal R, Kim J, Rajasekhara S, Haas M, Smith J, Desai V, Donovan KA, Portman D. Edmonton Symptom Assessment Scale and Clinical Characteristics Associated With Cannabinoid Use in Oncology Supportive Care Outpatients. J Natl Compr Canc Netw 2019;17:1059-64. [PMID: 31487688 DOI: 10.6004/jnccn.2019.7301] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
36 Sidhpura N, Parsons LH. Endocannabinoid-mediated synaptic plasticity and addiction-related behavior. Neuropharmacology 2011;61:1070-87. [PMID: 21669214 DOI: 10.1016/j.neuropharm.2011.05.034] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
37 Magotti P, Bauer I, Igarashi M, Babagoli M, Marotta R, Piomelli D, Garau G. Structure of human N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: regulation of fatty acid ethanolamide biosynthesis by bile acids. Structure 2015;23:598-604. [PMID: 25684574 DOI: 10.1016/j.str.2014.12.018] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 9.3] [Reference Citation Analysis]
38 McKillop AM, Moran BM, Abdel-Wahab YH, Flatt PR. Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice. Br J Pharmacol 2013;170:978-90. [PMID: 23992544 DOI: 10.1111/bph.12356] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 6.9] [Reference Citation Analysis]
39 Lowe H, Toyang N, Steele B, Bryant J, Ngwa W. The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases. Int J Mol Sci 2021;22:9472. [PMID: 34502379 DOI: 10.3390/ijms22179472] [Reference Citation Analysis]
40 Hodge RJ, Paulik MA, Walker A, Boucheron JA, McMullen SL, Gillmor DS, Nunez DJ. Weight and Glucose Reduction Observed with a Combination of Nutritional Agents in Rodent Models Does Not Translate to Humans in a Randomized Clinical Trial with Healthy Volunteers and Subjects with Type 2 Diabetes. PLoS One 2016;11:e0153151. [PMID: 27093610 DOI: 10.1371/journal.pone.0153151] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
41 Stadel R, Ahn KH, Kendall DA. The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail. J Neurochem 2011;117:1-18. [PMID: 21244428 DOI: 10.1111/j.1471-4159.2011.07186.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
42 Uranga JA, Vera G, Abalo R. Cannabinoid pharmacology and therapy in gut disorders. Biochem Pharmacol 2018;157:134-47. [PMID: 30076849 DOI: 10.1016/j.bcp.2018.07.048] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
43 André A, Gonthier MP. The endocannabinoid system: its roles in energy balance and potential as a target for obesity treatment. Int J Biochem Cell Biol 2010;42:1788-801. [PMID: 20541029 DOI: 10.1016/j.biocel.2010.06.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
44 Drzazga A, Kristinsson H, Sałaga M, Zatorski H, Koziołkiewicz M, Gendaszewska-Darmach E, Bergsten P. Lysophosphatidylcholine and its phosphorothioate analogues potentiate insulin secretion via GPR40 (FFAR1), GPR55 and GPR119 receptors in a different manner. Mol Cell Endocrinol 2018;472:117-25. [PMID: 29225068 DOI: 10.1016/j.mce.2017.12.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
45 Elmariah SB. Adjunctive Management of Itch in Atopic Dermatitis. Dermatol Clin 2017;35:373-94. [PMID: 28577806 DOI: 10.1016/j.det.2017.02.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
46 Serrano A, Parsons LH. Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors. Pharmacol Ther 2011;132:215-41. [PMID: 21798285 DOI: 10.1016/j.pharmthera.2011.06.005] [Cited by in Crossref: 108] [Cited by in F6Publishing: 97] [Article Influence: 10.8] [Reference Citation Analysis]
47 Schicho R, Storr M. Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies. Expert Rev Clin Pharmacol 2010;3:193-207. [PMID: 22111567 DOI: 10.1586/ecp.09.62] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
48 Depommier C, Flamand N, Pelicaen R, Maiter D, Thissen JP, Loumaye A, Hermans MP, Everard A, Delzenne NM, Di Marzo V, Cani PD. Linking the Endocannabinoidome with Specific Metabolic Parameters in an Overweight and Insulin-Resistant Population: From Multivariate Exploratory Analysis to Univariate Analysis and Construction of Predictive Models. Cells 2021;10:E71. [PMID: 33466285 DOI: 10.3390/cells10010071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Toguri J, Leishman E, Szczesniak A, Laprairie R, Oehler O, Straiker A, Kelly M, Bradshaw H. Inflammation and CB2 signaling drive novel changes in the ocular lipidome and regulate immune cell activity in the eye. Prostaglandins & Other Lipid Mediators 2018;139:54-62. [DOI: 10.1016/j.prostaglandins.2018.09.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
50 Schurman LD, Lu D, Kendall DA, Howlett AC, Lichtman AH. Molecular Mechanism and Cannabinoid Pharmacology. Handb Exp Pharmacol 2020;258:323-53. [PMID: 32236882 DOI: 10.1007/164_2019_298] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
51 Hesselink JM. Chronic idiopathic axonal neuropathy and pain, treated with the endogenous lipid mediator palmitoylethanolamide: a case collection. Int Med Case Rep J 2013;6:49-53. [PMID: 24049461 DOI: 10.2147/IMCRJ.S51572] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
52 Balenga NA, Henstridge CM, Kargl J, Waldhoer M. Pharmacology, signaling and physiological relevance of the G protein-coupled receptor 55. Adv Pharmacol 2011;62:251-77. [PMID: 21907912 DOI: 10.1016/B978-0-12-385952-5.00004-X] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
53 Keppel Hesselink JM, Kopsky DJ. Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome. J Pain Res 2015;8:729-34. [PMID: 26604814 DOI: 10.2147/JPR.S93106] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
54 Serrano A, Pavon FJ, Suarez J, Romero-cuevas M, Baixeras E, Goya P, de Fonseca FR. Obesity and the Endocannabinoid System: Is There Still a Future for CB1 Antagonists in Obesity? Curr Obes Rep 2012;1:216-28. [DOI: 10.1007/s13679-012-0031-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
55 Luschnig P, Schicho R. Cannabinoids in Gynecological Diseases. Med Cannabis Cannabinoids 2019;2:14-21. [PMID: 34676329 DOI: 10.1159/000499164] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
56 Tóth KF, Ádám D, Bíró T, Oláh A. Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System. Molecules 2019;24:E918. [PMID: 30845666 DOI: 10.3390/molecules24050918] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 30.5] [Reference Citation Analysis]
57 Pavón FJ, Serrano A, Romero-cuevas M, Alonso M, Rodríguez de Fonseca F. Oleoylethanolamide: a new player in peripheral control of energy metabolism. Therapeutic implications. Drug Discovery Today: Disease Mechanisms 2010;7:e175-83. [DOI: 10.1016/j.ddmec.2011.02.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
58 Mattace Raso G, Russo R, Calignano A, Meli R. Palmitoylethanolamide in CNS health and disease. Pharmacol Res 2014;86:32-41. [PMID: 24844438 DOI: 10.1016/j.phrs.2014.05.006] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 11.6] [Reference Citation Analysis]
59 Toczek M, Malinowska B. Enhanced endocannabinoid tone as a potential target of pharmacotherapy. Life Sci 2018;204:20-45. [PMID: 29729263 DOI: 10.1016/j.lfs.2018.04.054] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 16.0] [Reference Citation Analysis]
60 Pacher P, Mechoulam R. Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog Lipid Res. 2011;50:193-211. [PMID: 21295074 DOI: 10.1016/j.plipres.2011.01.001] [Cited by in Crossref: 279] [Cited by in F6Publishing: 259] [Article Influence: 27.9] [Reference Citation Analysis]
61 Oka S, Kimura S, Toshida T, Ota R, Yamashita A, Sugiura T. Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells. J Biochem 2010;147:671-8. [PMID: 20051382 DOI: 10.1093/jb/mvp208] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 5.9] [Reference Citation Analysis]
62 Bukiya AN. Physiology of the Endocannabinoid System During Development. Adv Exp Med Biol 2019;1162:13-37. [PMID: 31332732 DOI: 10.1007/978-3-030-21737-2_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Akimov MG, Ashba AM, Fomina-Ageeva EV, Gretskaya NM, Myasoedov NF, Bezuglov VV. Neuroprotective Action of Amidic Neurolipins in Models of Neurotoxicity on the Culture of Human Neural-Like Cells SH-SY5Y. Dokl Biochem Biophys 2019;485:141-4. [PMID: 31201636 DOI: 10.1134/S1607672919020182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Schicho R, Storr M. Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases. Can J Gastroenterol 2011;25:377-83. [PMID: 21876860 DOI: 10.1155/2011/953975] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
65 Im DS. GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide. Int J Mol Sci 2021;22:1034. [PMID: 33494185 DOI: 10.3390/ijms22031034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
66 Jenkin KA, McAinch AJ, Grinfeld E, Hryciw DH. Role for cannabinoid receptors in human proximal tubular hypertrophy. Cell Physiol Biochem 2010;26:879-86. [PMID: 21220919 DOI: 10.1159/000323997] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
67 Montecucco F, Lenglet S, Quercioli A, Burger F, Thomas A, Lauer E, Silva ARD, Mach F, Vuilleumier N, Bobbioni-harsch E, Golay A, Schindler TH, Pataky Z. Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways. Thromb Haemost 2017;113:838-50. [DOI: 10.1160/th14-06-0506] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
68 Musella A, Fresegna D, Rizzo FR, Gentile A, Bullitta S, De Vito F, Guadalupi L, Centonze D, Mandolesi G. A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum. Sci Rep 2017;7:7363. [PMID: 28779174 DOI: 10.1038/s41598-017-07519-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
69 Armeli F, Bonucci A, Maggi E, Pinto A, Businaro R. Mediterranean Diet and Neurodegenerative Diseases: The Neglected Role of Nutrition in the Modulation of the Endocannabinoid System. Biomolecules 2021;11:790. [PMID: 34073983 DOI: 10.3390/biom11060790] [Reference Citation Analysis]
70 Piscitelli F. Endocannabinoidomics: “Omics” Approaches Applied to Endocannabinoids and Endocannabinoid-Like Mediators. The Endocannabinoidome. Elsevier; 2015. pp. 137-52. [DOI: 10.1016/b978-0-12-420126-2.00009-2] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
71 Aggarwal G, Zarrow JE, Mashhadi Z, Flynn CR, Vinson P, Weaver CD, Davies SS. Symmetrically substituted dichlorophenes inhibit N-acyl-phosphatidylethanolamine phospholipase D. J Biol Chem 2020;295:7289-300. [PMID: 32284327 DOI: 10.1074/jbc.RA120.013362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
72 Herrera MI, Kölliker-Frers R, Barreto G, Blanco E, Capani F. Glial Modulation by N-acylethanolamides in Brain Injury and Neurodegeneration. Front Aging Neurosci 2016;8:81. [PMID: 27199733 DOI: 10.3389/fnagi.2016.00081] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
73 Di Pietro F, Macey PM, Rae CD, Alshelh Z, Macefield VG, Vickers ER, Henderson LA. The relationship between thalamic GABA content and resting cortical rhythm in neuropathic pain. Hum Brain Mapp 2018;39:1945-56. [PMID: 29341331 DOI: 10.1002/hbm.23973] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
74 Zhou Y, Wang Y, Zhang L, Tang C, Feng B. Discovery and biological evaluation of novel G protein-coupled receptor 119 agonists for type 2 diabetes. Arch Pharm (Weinheim) 2019;352:e1800267. [PMID: 30740769 DOI: 10.1002/ardp.201800267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
75 Félétou M. The Endothelium, Part II: EDHF-Mediated Responses "The Classical Pathway". Colloquium Series on Integrated Systems Physiology: From Molecule to Function 2011;3:1-306. [DOI: 10.4199/c00032ed1v01y201105isp020] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
76 Marzo VD, Petrocellis LD. Fifty years of ‘cannabinoid research’ and the need for a new nomenclature. In: Di Marzo V, editor. Cannabinoids. Chichester: John Wiley & Sons, Ltd; 2014. pp. 261-89. [DOI: 10.1002/9781118451281.ch8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
77 Piñeiro R, Falasca M. Lysophosphatidylinositol signalling: New wine from an old bottle. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2012;1821:694-705. [DOI: 10.1016/j.bbalip.2012.01.009] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 6.4] [Reference Citation Analysis]
78 Petrosino S, Schiano Moriello A, Cerrato S, Fusco M, Puigdemont A, De Petrocellis L, Di Marzo V. The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels. Br J Pharmacol 2016;173:1154-62. [PMID: 25598150 DOI: 10.1111/bph.13084] [Cited by in Crossref: 63] [Cited by in F6Publishing: 67] [Article Influence: 10.5] [Reference Citation Analysis]
79 Tufano M, Pinna G. Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders? Molecules 2020;25:E1062. [PMID: 32120979 DOI: 10.3390/molecules25051062] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
80 Voitychuk OI, Asmolkova VS, Gula NM, Sotkis GV, Galadari S, Howarth FC, Oz M, Shuba YM. Modulation of excitability, membrane currents and survival of cardiac myocytes by N-acylethanolamines. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2012;1821:1167-76. [DOI: 10.1016/j.bbalip.2012.05.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
81 Penumarti A, Abdel-Rahman AA. The novel endocannabinoid receptor GPR18 is expressed in the rostral ventrolateral medulla and exerts tonic restraining influence on blood pressure. J Pharmacol Exp Ther 2014;349:29-38. [PMID: 24431468 DOI: 10.1124/jpet.113.209213] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
82 Sharir H, Abood ME. Pharmacological characterization of GPR55, a putative cannabinoid receptor. Pharmacol Ther. 2010;126:301-313. [PMID: 20298715 DOI: 10.1016/j.pharmthera.2010.02.004] [Cited by in Crossref: 128] [Cited by in F6Publishing: 124] [Article Influence: 11.6] [Reference Citation Analysis]
83 Paloczi J, Varga ZV, Hasko G, Pacher P. Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation. Antioxid Redox Signal 2018;29:75-108. [PMID: 28497982 DOI: 10.1089/ars.2017.7144] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 10.5] [Reference Citation Analysis]
84 Katz LB, Gambale JJ, Rothenberg PL, Vanapalli SR, Vaccaro N, Xi L, Polidori DC, Vets E, Sarich TC, Stein PP. Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of JNJ-38431055, a Novel GPR119 Receptor Agonist and Potential Antidiabetes Agent, in Healthy Male Subjects. Clin Pharmacol Ther 2011;90:685-92. [DOI: 10.1038/clpt.2011.169] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
85 Rimmerman N, Bradshaw HB, Kozela E, Levy R, Juknat A, Vogel Z. Compartmentalization of endocannabinoids into lipid rafts in a microglial cell line devoid of caveolin-1. Br J Pharmacol 2012;165:2436-49. [PMID: 21449981 DOI: 10.1111/j.1476-5381.2011.01380.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
86 Locci A, Pinna G. Stimulation of Peroxisome Proliferator-Activated Receptor-α by N-Palmitoylethanolamine Engages Allopregnanolone Biosynthesis to Modulate Emotional Behavior. Biol Psychiatry 2019;85:1036-45. [PMID: 30955840 DOI: 10.1016/j.biopsych.2019.02.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
87 McKillop AM, Moran BM, Abdel-Wahab YH, Gormley NM, Flatt PR. Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice. Diabetologia 2016;59:2674-85. [PMID: 27677765 DOI: 10.1007/s00125-016-4108-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
88 Keppel Hesselink JM, Kopsky DJ. Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells. J Pain Res 2013;6:239-45. [PMID: 23658493 DOI: 10.2147/JPR.S42417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
89 Mollanazar NK, Smith PK, Yosipovitch G. Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out? Clinic Rev Allerg Immunol 2016;51:263-92. [DOI: 10.1007/s12016-015-8488-5] [Cited by in Crossref: 148] [Cited by in F6Publishing: 123] [Article Influence: 24.7] [Reference Citation Analysis]
90 Gebeh AK, Willets JM, Bari M, Hirst RA, Marczylo TH, Taylor AH, Maccarrone M, Konje JC. Elevated anandamide and related N-acylethanolamine levels occur in the peripheral blood of women with ectopic pregnancy and are mirrored by changes in peripheral fatty acid amide hydrolase activity. J Clin Endocrinol Metab 2013;98:1226-34. [PMID: 23372171 DOI: 10.1210/jc.2012-3390] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
91 Bialuk I, Winnicka MM. AM251, cannabinoids receptors ligand, improves recognition memory in rats. Pharmacological Reports 2011;63:670-9. [DOI: 10.1016/s1734-1140(11)70578-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
92 Walter C, Ferreirós N, Bishay P, Geisslinger G, Tegeder I, Lötsch J. Exogenous Delta9-Tetrahydrocannabinol Influences Circulating Endogenous Cannabinoids in Humans. Journal of Clinical Psychopharmacology 2013;33:699-705. [DOI: 10.1097/jcp.0b013e3182984015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
93 Fellous TG, Redpath AN, Fleischer MM, Gandhi S, Hartner SE, Newton MD, François M, Wong SP, Gowers KHC, Fahs AM, Possley DR, Bonnet D, Urquhart P, Nicolaou A, Baker KC, Rankin SM. Pharmacological tools to mobilise mesenchymal stromal cells into the blood promote bone formation after surgery. NPJ Regen Med 2020;5:3. [PMID: 32133156 DOI: 10.1038/s41536-020-0088-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
94 Cordaro M, Cuzzocrea S, Crupi R. An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events. Antioxidants (Basel) 2020;9:E216. [PMID: 32150935 DOI: 10.3390/antiox9030216] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
95 Giuffrida A, Seillier A. New insights on endocannabinoid transmission in psychomotor disorders. Prog Neuropsychopharmacol Biol Psychiatry 2012;38:51-8. [PMID: 22521335 DOI: 10.1016/j.pnpbp.2012.04.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
96 Marichal-Cancino BA, Fajardo-Valdez A, Ruiz-Contreras AE, Mendez-Díaz M, Prospero-García O. Advances in the Physiology of GPR55 in the Central Nervous System. Curr Neuropharmacol 2017;15:771-8. [PMID: 27488130 DOI: 10.2174/1570159X14666160729155441] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
97 Hurst K, Badgley C, Ellsworth T, Bell S, Friend L, Prince B, Welch J, Cowan Z, Williamson R, Lyon C, Anderson B, Poole B, Christensen M, McNeil M, Call J, Edwards JG. A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity. Hippocampus 2017;27:985-98. [PMID: 28653801 DOI: 10.1002/hipo.22747] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
98 Gao Y, Li Y, Tan Y, Liu W, Ouaddi S, McCoy J, Kovacevic M, Situm M, Stanimirovic A, Li M, Wambier C, Goren A, Zou Y. Novel cannabidiol aspartame combination treatment (JW-100) significantly reduces ISGA score in atopic dermatitis: Results from a randomized double-blinded placebo-controlled interventional study. J Cosmet Dermatol 2021. [PMID: 34056830 DOI: 10.1111/jocd.14263] [Reference Citation Analysis]
99 Lötsch J, Weyer-Menkhoff I, Tegeder I. Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings. Eur J Pain 2018;22:471-84. [PMID: 29160600 DOI: 10.1002/ejp.1148] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 14.8] [Reference Citation Analysis]
100 Kumar A, Qiao Z, Kumar P, Song ZH. Effects of palmitoylethanolamide on aqueous humor outflow. Invest Ophthalmol Vis Sci 2012;53:4416-25. [PMID: 22589443 DOI: 10.1167/iovs.11-9294] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
101 Zlebnik NE, Cheer JF. Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions. J Neurosci 2016;36:10230-8. [PMID: 27707960 DOI: 10.1523/JNEUROSCI.1712-16.2016] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
102 Weis F, Beiras-fernandez A, Sodian R, Kaczmarek I, Reichart B, Beiras A, Schelling G, Kreth S. Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure. Journal of Molecular and Cellular Cardiology 2010;48:1187-93. [DOI: 10.1016/j.yjmcc.2009.10.025] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
103 Zambrana-infantes E, Rosell del Valle C, Ladrón de Guevara-miranda D, Galeano P, Castilla-ortega E, Rodríguez De Fonseca F, Blanco E, Santín LJ. Palmitoylethanolamide attenuates cocaine-induced behavioral sensitization and conditioned place preference in mice. Pharmacology Biochemistry and Behavior 2018;166:1-12. [DOI: 10.1016/j.pbb.2018.01.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
104 Bandyopadhayaya S, Akimov MG, Verma R, Sharma A, Sharma D, Kundu GC, Gretskaya NM, Bezuglov VV, Mandal CC. N-arachidonoyl dopamine inhibits epithelial-mesenchymal transition of breast cancer cells through ERK signaling and decreasing the cellular cholesterol. J Biochem Mol Toxicol 2021;35:e22693. [PMID: 33393692 DOI: 10.1002/jbt.22693] [Reference Citation Analysis]
105 Cable JC, Tan GD, Alexander SP, O'Sullivan SE. The effects of obesity, diabetes and metabolic syndrome on the hydrolytic enzymes of the endocannabinoid system in animal and human adipocytes. Lipids Health Dis 2014;13:43. [PMID: 24593280 DOI: 10.1186/1476-511X-13-43] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
106 Sałaga M, Abalo R, Fichna J. Cannabis and Cannabinoids and the Effects on Gastrointestinal Function: An Overview. Handbook of Cannabis and Related Pathologies. Elsevier; 2017. pp. 471-80. [DOI: 10.1016/b978-0-12-800756-3.00056-9] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
107 Hammell DC, Zhang LP, Ma F, Abshire SM, McIlwrath SL, Stinchcomb AL, Westlund KN. Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis. Eur J Pain 2016;20:936-48. [PMID: 26517407 DOI: 10.1002/ejp.818] [Cited by in Crossref: 87] [Cited by in F6Publishing: 76] [Article Influence: 14.5] [Reference Citation Analysis]
108 Ayakannu T, Taylor AH, Marczylo TH, Willets JM, Konje JC. The endocannabinoid system and sex steroid hormone-dependent cancers. Int J Endocrinol 2013;2013:259676. [PMID: 24369462 DOI: 10.1155/2013/259676] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
109 Gao J, Tian L, Weng G, Bhagroo NV, Sorenson RL, O'Brien TD, Luo J, Guo Z. Stimulating beta cell replication and improving islet graft function by GPR119 agonists. Transpl Int 2011;24:1124-34. [PMID: 21902730 DOI: 10.1111/j.1432-2277.2011.01332.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
110 Kumar P, Kumar A, Song ZH. Structure-activity relationships of fatty acid amide ligands in activating and desensitizing G protein-coupled receptor 119. Eur J Pharmacol 2014;723:465-72. [PMID: 24184668 DOI: 10.1016/j.ejphar.2013.10.044] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
111 Sayd A, Antón M, Alén F, Caso JR, Pavón J, Leza JC, Rodríguez de Fonseca F, García-Bueno B, Orio L. Systemic administration of oleoylethanolamide protects from neuroinflammation and anhedonia induced by LPS in rats. Int J Neuropsychopharmacol 2014;18:pyu111. [PMID: 25548106 DOI: 10.1093/ijnp/pyu111] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
112 Morri M, Sanchez-Romero I, Tichy AM, Kainrath S, Gerrard EJ, Hirschfeld PP, Schwarz J, Janovjak H. Optical functionalization of human Class A orphan G-protein-coupled receptors. Nat Commun 2018;9:1950. [PMID: 29769519 DOI: 10.1038/s41467-018-04342-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
113 Park S, Kim J, Oh S, Cha W, Hah J, Sung M. Anticancer effects of anandamide on head and neck squamous cell carcinoma cells via the production of receptor-independent reactive oxygen species: Anandamide and HNSCC cell death. Head Neck 2015;37:1187-92. [DOI: 10.1002/hed.23727] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
114 Stasiulewicz A, Znajdek K, Grudzień M, Pawiński T, Sulkowska AJI. A Guide to Targeting the Endocannabinoid System in Drug Design. Int J Mol Sci 2020;21:E2778. [PMID: 32316328 DOI: 10.3390/ijms21082778] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 30.0] [Reference Citation Analysis]
115 Grzelczyk A, Gendaszewska-Darmach E. Novel bioactive glycerol-based lysophospholipids: new data -- new insight into their function. Biochimie 2013;95:667-79. [PMID: 23089136 DOI: 10.1016/j.biochi.2012.10.009] [Cited by in Crossref: 85] [Cited by in F6Publishing: 75] [Article Influence: 9.4] [Reference Citation Analysis]
116 Oláh A, Szekanecz Z, Bíró T. Targeting Cannabinoid Signaling in the Immune System: "High"-ly Exciting Questions, Possibilities, and Challenges. Front Immunol 2017;8:1487. [PMID: 29176975 DOI: 10.3389/fimmu.2017.01487] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 15.0] [Reference Citation Analysis]
117 Li C, Jones PM, Persaud SJ. Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas. Pharmacology & Therapeutics 2011;129:307-20. [DOI: 10.1016/j.pharmthera.2010.10.006] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 6.5] [Reference Citation Analysis]
118 Pyszniak M, Tabarkiewicz J, Łuszczki JJ. Endocannabinoid system as a regulator of tumor cell malignancy - biological pathways and clinical significance. Onco Targets Ther 2016;9:4323-36. [PMID: 27486335 DOI: 10.2147/OTT.S106944] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
119 Ayakannu T, Taylor AH, Willets JM, Konje JC. The evolving role of the endocannabinoid system in gynaecological cancer. Hum Reprod Update 2015;21:517-35. [PMID: 25958409 DOI: 10.1093/humupd/dmv022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
120 Izzo AA, Sharkey KA. Cannabinoids and the gut: new developments and emerging concepts. Pharmacol Ther. 2010;126:21-38. [PMID: 20117132 DOI: 10.1016/j.pharmthera.2009.12.005] [Cited by in Crossref: 272] [Cited by in F6Publishing: 248] [Article Influence: 24.7] [Reference Citation Analysis]
121 Das G, Das T, Chowdhury N, Chatterjee D, Bagchi A, Ghosh Z. Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19. Genomics 2021;113:1129-40. [PMID: 33189776 DOI: 10.1016/j.ygeno.2020.11.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
122 Rivera P, Romero-Zerbo Y, Pavón FJ, Serrano A, López-Ávalos MD, Cifuentes M, Grondona JM, Bermúdez-Silva FJ, Fernández-Llebrez P, de Fonseca FR, Suárez J, Pérez-Martín M. Obesity-dependent cannabinoid modulation of proliferation in adult neurogenic regions. Eur J Neurosci 2011;33:1577-86. [PMID: 21395869 DOI: 10.1111/j.1460-9568.2011.07650.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
123 Fonseca BM, Correia-da-Silva G, Almada M, Costa MA, Teixeira NA. The Endocannabinoid System in the Postimplantation Period: A Role during Decidualization and Placentation. Int J Endocrinol 2013;2013:510540. [PMID: 24228028 DOI: 10.1155/2013/510540] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
124 Malek N, Kostrzewa M, Makuch W, Pajak A, Kucharczyk M, Piscitelli F, Przewlocka B, Di Marzo V, Starowicz K. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain. Pharmacol Res 2016;111:251-63. [PMID: 27326920 DOI: 10.1016/j.phrs.2016.06.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
125 Tanaka K, Mayne L, Khalil A, Baartz D, Eriksson L, Mortlock SA, Montgomery G, McKinnon B, Amoako AA. The role of the endocannabinoid system in aetiopathogenesis of endometriosis: A potential therapeutic target. Eur J Obstet Gynecol Reprod Biol 2020;244:87-94. [PMID: 31785471 DOI: 10.1016/j.ejogrb.2019.11.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
126 Fotio Y, Ciccocioppo R, Piomelli D. N-acylethanolamine acid amidase (NAAA) inhibition decreases the motivation for alcohol in Marchigian Sardinian alcohol-preferring rats. Psychopharmacology (Berl) 2021;238:249-58. [PMID: 33037452 DOI: 10.1007/s00213-020-05678-7] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
127 Ford GK, Kieran S, Dolan K, Harhen B, Finn DP. A role for the ventral hippocampal endocannabinoid system in fear-conditioned analgesia and fear responding in the presence of nociceptive tone in rats. Pain 2011;152:2495-504. [PMID: 21864979 DOI: 10.1016/j.pain.2011.07.014] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
128 Bambang KN, Karasu T, Gebeh A, Taylor AH, Marczylo TH, Lam P, Willets JM, Konje JC. From Fertilisation to Implantation in Mammalian Pregnancy-Modulation of Early Human Reproduction by the Endocannabinoid System. Pharmaceuticals (Basel) 2010;3:2910-29. [PMID: 27713383 DOI: 10.3390/ph3092910] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
129 Pan X, Schwartz GJ, Hussain MM. Oleoylethanolamide differentially regulates glycerolipid synthesis and lipoprotein secretion in intestine and liver. J Lipid Res 2018;59:2349-59. [PMID: 30369486 DOI: 10.1194/jlr.M089250] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
130 Gugliandolo E, Peritore AF, Piras C, Cuzzocrea S, Crupi R. Palmitoylethanolamide and Related ALIAmides: Prohomeostatic Lipid Compounds for Animal Health and Wellbeing. Vet Sci 2020;7:E78. [PMID: 32560159 DOI: 10.3390/vetsci7020078] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
131 Keppel Hesselink JM, de Boer T, Witkamp RF. Palmitoylethanolamide: A Natural Body-Own Anti-Inflammatory Agent, Effective and Safe against Influenza and Common Cold. Int J Inflam 2013;2013:151028. [PMID: 24066256 DOI: 10.1155/2013/151028] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
132 Singh D, Fisher J, Shagalov D, Varma A, Siegel DM. Dangerous plants in dermatology: Legal and controlled. Clin Dermatol 2018;36:399-419. [PMID: 29908582 DOI: 10.1016/j.clindermatol.2018.03.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 Murru E, Carta G, Manca C, Sogos V, Pistis M, Melis M, Banni S. Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation. Front Pharmacol 2020;11:587140. [PMID: 33505308 DOI: 10.3389/fphar.2020.587140] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
134 Rimmerman N, Kozela E, Levy R, Vogel Z, Juknat A. Cannabinoid Signaling Through Non-CB1R/Non-CB2R Targets in Microglia. In: Abood ME, Sorensen RG, Stella N, editors. endoCANNABINOIDS. New York: Springer; 2013. pp. 143-71. [DOI: 10.1007/978-1-4614-4669-9_7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
135 Iannotti FA, Di Marzo V, Petrosino S. Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders. Progress in Lipid Research 2016;62:107-28. [DOI: 10.1016/j.plipres.2016.02.002] [Cited by in Crossref: 180] [Cited by in F6Publishing: 170] [Article Influence: 36.0] [Reference Citation Analysis]
136 Martella A, Sepe RM, Silvestri C, Zang J, Fasano G, Carnevali O, De Girolamo P, Neuhauss SCF, Sordino P, Di Marzo V. Important role of endocannabinoid signaling in the development of functional vision and locomotion in zebrafish. FASEB j 2016;30:4275-88. [DOI: 10.1096/fj.201600602r] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 3.4] [Reference Citation Analysis]